Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Nofech-Mozes

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Obstetrics and Gynecology|June 24, 2009
Evaluation of two management strategies for preoperative grade 1 endometrial cancerMarcus Q Bernardini, Taymaa May, Mahmoud A Khalifa, et al.
The American Journal of Surgical Pathology|July 24, 2019
p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic AnalysisCarlos Parra-Herran, Dina Bassiouny, Jordan Lerner-Ellis, et al.
Histopathology|November 30, 2019
Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systemsAurelia Busca, Sharon Nofech-Mozes, Ekaterina Olkhov-Mitsel, et al.
Annals of Diagnostic Pathology|July 17, 2007
Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasionNadia Ismiil, Golnar Rasty, Zeina Ghorab, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 17, 2012
Systematic review on hormone receptor testing in breast cancerSharon Nofech-Mozes, Emily T Vella, Sukhbinder Dhesy-Thind, et al.
The American Journal of Surgical Pathology|August 10, 2020
CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient OutcomeRoman E Zyla, Ekaterina Olkhov-Mitsel, Yutaka Amemiya, et al.
Gynecologic Oncology|October 4, 2023
Budget impact analysis of molecular subtype profiling in endometrial cancerAnna Plotkin, Ekaterina Olkhov-Mitsel, Sharon Nofech-Mozes, et al.
Breast Cancer Research and Treatment|January 27, 2022
Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapyDanielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, et al.
Clinical Medicine. Oncology|September 6, 2011
Biological Markers Predictive of Invasive Recurrence in DCISSharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 22, 2007
Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinomaNadia D Ismiil, Golnar Rasty, Zeina Ghorab, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Obstetrics and Gynecology|June 24, 2009
Evaluation of two management strategies for preoperative grade 1 endometrial cancerMarcus Q Bernardini, Taymaa May, Mahmoud A Khalifa, et al.
The American Journal of Surgical Pathology|July 24, 2019
p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic AnalysisCarlos Parra-Herran, Dina Bassiouny, Jordan Lerner-Ellis, et al.
Histopathology|November 30, 2019
Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systemsAurelia Busca, Sharon Nofech-Mozes, Ekaterina Olkhov-Mitsel, et al.
Annals of Diagnostic Pathology|July 17, 2007
Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasionNadia Ismiil, Golnar Rasty, Zeina Ghorab, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 17, 2012
Systematic review on hormone receptor testing in breast cancerSharon Nofech-Mozes, Emily T Vella, Sukhbinder Dhesy-Thind, et al.
The American Journal of Surgical Pathology|August 10, 2020
CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient OutcomeRoman E Zyla, Ekaterina Olkhov-Mitsel, Yutaka Amemiya, et al.
Gynecologic Oncology|October 4, 2023
Budget impact analysis of molecular subtype profiling in endometrial cancerAnna Plotkin, Ekaterina Olkhov-Mitsel, Sharon Nofech-Mozes, et al.
Breast Cancer Research and Treatment|January 27, 2022
Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapyDanielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, et al.
Clinical Medicine. Oncology|September 6, 2011
Biological Markers Predictive of Invasive Recurrence in DCISSharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 22, 2007
Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinomaNadia D Ismiil, Golnar Rasty, Zeina Ghorab, et al.
Pageof 13